Public Company News
Xtep Launches Inaugural X-RUN CAMP for The Standard Chartered Heritage Marathon Hanoi in Vietnam
HANOI, Vietnam, Oct. 21, 2025 /PRNewswire/ -- As the strategic technology partner and exclusive gear sponsor of The Standard Chartered Heritage Marathon Hanoi, Xtep proudly supported the official launch of the SCHM X-RUN CAMP, held onOctober 19, 2025. Co-hosted by Xtep and Standard Chartered, the...
2025-10-21 11:27
2018
Trinasolar and Mestron Energy Ink MOU to Strengthen Malaysia's National Energy Transition Roadmap Goals
Partnership to supply 50MW of Vertex N-type modules for renewable projects acrossMalaysia. SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- Trinasolar, a global leader in smart photovoltaic (PV) and energy storage solutions, has signed a memorandum of understanding (MoU) with Mestron Energy, a specialis...
2025-10-21 10:00
1744
Orbbec Captures 72% of Korea's Mobile Robot 3D Vision Market, New Report Shows
SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- Global market research firm Interact
Analysis
2025-10-21 10:00
1366
Investor Conference Call and Webcast on Shaakichiuwaanaan Project - Lithium-Only Feasibility Study Results
PMET Resources President and CEO Ken Brinsden to host an investor call MONTREAL and SYDNEY, Oct. 21, 2025 /PRNewswire/ -- PMET Resources Inc. (the "Company" or "PMET") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to advise that it will host a live investor teleconference and webca...
2025-10-21 05:45
959
PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project
Unlocking Shaakichiuwaanaan's maiden Mineral Reserve and a key step towards final mine authorisation MONTREAL, Oct. 21, 2025 /PRNewswire/ -- October 21, 2025 – Sydney, Australia Highlights * Robust CV5 lithium-only Feasibility Study ("FS") completed on the Shaakichiuwaanaan Project (Project) ...
2025-10-21 05:45
891
SM Investments certified as a Great Place to Work® in 2025
PASAY CITY, Philippines , Oct. 20, 2025 /PRNewswire/ -- SM Investments
Corporation (SM Investments), the parent company of the SM group, has been
certified as a Great Place to Work for 2025 by the global authority on
workplace culture, Great Place to Work®.
2025-10-20 20:45
1440
IBM and Groq Partner to Accelerate Enterprise AI Deployment with Speed and Scale
Partnership aims to deliver faster agentic AI capabilities through IBM watsonx
Orchestrate and Groq technology, enabling enterprise clients to take immediate
action on complex workflows
ARMONK, N.Y. and MOUNTAIN VIEW, Calif., Oct. 20, 2025 /PRNewswire/ -- IBM
(NYSE:IBM
2025-10-20 18:09
1209
SKF at COP30: The world can't afford friction - it's time to scale what works
GOTHENBURG, Sweden, Oct. 20, 2025 /PRNewswire/ -- SKF will be attending COP30, held in Belém,Brazil in November 2025, to drive systemic change and progress through collaboration. A resilient industry demands open, systematic collaboration. SKF sees friction every day, in mindsets, metrics, and b...
2025-10-20 17:54
980
Tiger Brokers (Hong Kong) Sponsors CFA Institute Research Challenge -- Hong Kong Local Final for the First Time, Introducing the "Star Presenter" Award
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Tiger Brokers (Hong Kong) Global Limited ("Tiger Brokers (Hong Kong)") is proud to announce its inaugural sponsorship of the 2025–2026 CFA Institute Research Challenge — Hong Kong Local Final, underscoring the firm's commitment to talent development, profe...
2025-10-20 17:40
1830
The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC
* After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to 0.62; two-sided P<0.0001). * OS was significantly longer with sac-TMT than with chemotherapy (H...
2025-10-20 17:06
1375
Global Chinese Wealth Manager Noah Holdings Hosts Inaugural N+ Art Club Exhibition in Shanghai: Hub: The Endless Exploration of Art
Extending Trust Between Cultures & Generations Through "Wisdom • Wealth • A Life of Warmth" SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-sto...
2025-10-20 16:53
2360
ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma
BERLIN, Oct. 20, 2025 /PRNewswire/ -- At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing locally advanced or metastatic urothelial carcinoma (RC48-C016)...
2025-10-20 14:58
1608
3M at China Wind Power 2025: innovations empowering the future of green energy
BEIJING, Oct. 20, 2025 /PRNewswire/ -- On October 20, 2025, 3M, a global leader in diversified technology, made its appearance at the 2025 China Wind Power (CWP 2025). At this year's exhibition, 3M's booth theme was "With Wind as Wings, 3M Empowers a Green Future," focusing on showcasing innovativ...
2025-10-20 14:16
1331
Agoda Spotlights Unique Asian Airports Redefining the Layover Experience
SINGAPORE, Oct. 20, 2025 /PRNewswire/ -- Digital travel platform Agoda has unveiled a list of five airports inAsia that transform layovers into memorable experiences. These airports offer more than just transit, with attractions that cater to both short and long stops, inviting travelers to arriv...
2025-10-20 14:03
1111
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, Results from a Phase 3 study of the Company's human epidermal growth factor rece...
2025-10-20 13:59
1314
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- October 20, 2025- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrou...
2025-10-20 13:21
1227
Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 2025
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ovarian cancer (OC) and HER2-positive metastatic colore...
2025-10-20 13:15
1363
KLN Drives Libya's Wellhead Platform A Project Toward Completion, One of the Mediterranean Sea's Largest Offshore EPCI Projects to Bolster Energy Infrastructure
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK), through its division KLN Project, today announced significant progress on the Wellhead Platform A (WHPA) project inLibya's Bahr Essalam field. As consortium leader appointed by Mellitah Oil & Gas Co...
2025-10-20 12:29
1234
Nongshim Shin Ramyun Light Ups New York Times Square with 'KPop Demon Hunters'
- Global campaign celebrates the U.S. debut of the movie-inspired collaboration package - NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Nongshim carried out a global campaign at New York Times Square to celebrate the launch of Shin Ramyun in collaboration with Netflix's hit animated film 'KPop Demon H...
2025-10-20 11:23
1291
Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's trophoblast cell-s...
2025-10-20 10:36
1462
Week's Top Stories
Most Reposted
Agoda Launches Free Global eSIMs for VIP Diamond Members
[Picked up by 319 media titles]
2026-02-10 14:00
Mastercard Launches Portfolio of Fleet Solutions in Asia Pacific
[Picked up by 311 media titles]
2026-02-04 09:00Blackpanda Japan Announces Strategic Partnership with SoftBank to Strengthen Cyber Incident Response in Japan
[Picked up by 297 media titles]
2026-02-10 13:31Rockwell Automation Strengthens Industrial Cybersecurity with New Security Operations Center in Singapore
[Picked up by 296 media titles]
2026-02-09 10:00
InfoComm China Unveils State of China's Pro AV Market and Opportunities 2026 Industry White-Paper Report
[Picked up by 291 media titles]
2026-02-10 08:00
Most Read
Angel Yeast Indonesia Project: Strengthening Foundations through Technical Training and Building Consensus through Cultural Exchange
2026-02-07 09:31
7369
DaVinci Gourmet Named Title Sponsor of The World's 100 Best Coffee Shops 2026, to Be Unveiled in Madrid
2026-02-06 21:28
7366
Neurophet Secures FDA 510(k) Clearance for "Neurophet AQUA AD Plus," Marking Its Third U.S. Regulatory Milestone
2026-02-06 22:00
6565
/C O R R E C T I O N -- Fairland Group - iGarden/
2026-02-08 17:31
6495
